Drug Trial Radar · NCT07395687
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
Last checked: Nov 19, 2026Latest source record: Apr 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
333
Planned (sponsor's estimate)
Start
Feb 2, 2026
Primary completion
Jan 14, 2027
Study completion Feb 18, 2027
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Feb 9, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical study is to find out if UBT251 is safe and effective for treating people who are living with overweight or obesity. Participants will get either UBT251 (the treatment being tested) or Placebo (a treatment that has no active medicine in it), which treatment participants get is decided by chance.
Conditions
- Overweight
- Obesity
Interventions
UBT251Drug
UBT251 injection will be administered subcutaneously in a lifted fold of the abdominal skin.
PlaceboDrug
Placebo matched to UBT251 injection will be administered subcutaneously in a lifted fold of the abdominal skin.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A - Number of treatment emergent adverse events (TEAEs)Time frame: From baseline (week 0) to end of study (week 33)
- Part B - Relative change in body weightTime frame: From baseline (week 0) to end of treatment (week 28)
- Part C- AUC; the area under the UBT251 plasma concentration time curveTime frame: From pre-dose on Day 1 until completion of the end of study visit (Day 43)
Locations
3 sites in 2 countries. Site status is shown where the registry gives one.
Altasciences Clinical LA, Inc.
Cypress, California · Recruiting
Altasciences Clinical Kansas, Inc.
Overland Park, Kansas · Recruiting
Altasciences Clinical Company, Inc
Montreal, Quebec, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.